Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polyribonucleotide nucleotidyltransferase 1 pseudogene 2 is classified as a pseudogene, meaning it is a DNA sequence similar to that of a known gene but typically nonfunctional due to disabling mutations[5][1]. Unlike its parent gene (polyribonucleotide nucleotidyltransferase 1, which is mitochondrial polynucleotide phosphorylase), this pseudogene does not encode a functional protein and is not known to have a biological role or act as a drug target[5][1]. Pseudogenes are traditionally considered "dead" genes; although some can be transcribed, there is no evidence that PNPT1P2 has regulatory, protein-coding, or disease-associated functions[1][5]. There are no approved drugs, biomarker roles, or recognized safety concerns for this locus. If you are seeking a functional target, it may be a case of mistaken identity; refer instead to the parent gene, polyribonucleotide nucleotidyltransferase 1 (PNPT1), for possible enzymatic or disease-related roles.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyribonucleotide nucleotidyltransferase 1 pseudogene 2 (PNPT1P2).